http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107095876-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107095876-B |
| titleOfInvention | Diphenyl joins application of the alkenyl phosphine oxide compound in preparation treatment lung-cancer medicament |
| abstract | The present invention discloses application of the diphenyl connection alkenyl phosphine oxide compound in preparation treatment lung-cancer medicament, especially application of compound (1- phenyl -1, the 2- allene -1- base) diphenyl phosphine oxide in preparation adenocarcinoma of lung and lung squamous cancer drug.This compound can inhibit the growth of lung cancer tumor cell well, and mechanism is related to having no toxic side effect by promoting autophagy and activation MAPK access to promote its apoptosis. |
| priorityDate | 2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.